Blue Jet Healthcare Limited
NSE: BLUEJET BSE: BLUEJET
Prev Close
762.2
Open Price
761.4
Volume
402,801
Today Low / High
728 / 766.9
52 WK Low / High
347.6 / 968.3
Range
705 - 780
Prev Close
761.9
Open Price
743.1
Volume
25,210
Today Low / High
730 / 764.9
52 WK Low / High
346.7 / 968.75
Range
704 - 778
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 742.4 (target range: 705 - 780), reflecting a change of -19.8 (-2.59774%). On the BSE, it is listed at 741.2 (target range: 704 - 778), showing a change of -20.7 (-2.71689%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Blue Jet Healthcare Limited Graph
Blue Jet Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Blue Jet Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 742.40, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 741.20 | 748.61 | 673.75 - 823.47 |
| 756.02 | 604.82 - 907.23 | ||
| 763.44 | 534.41 - 992.47 | ||
| Bearish Scenario | 741.20 | 733.79 | 660.41 - 807.17 |
| 726.38 | 581.10 - 871.65 | ||
| 718.96 | 503.27 - 934.65 |
Overview of Blue Jet Healthcare Limited
ISIN
INE0KBH01020
Industry
Biotechnology
Vol.Avg
567,637
Market Cap
128,780,727,808
Last Dividend
1
Official Website
IPO Date
2023-11-01
DCF Diff
567.06
DCF
165
Financial Ratios Every Investor Needs
Stock Dividend of BLUEJET
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-17 | September 17, 24 | 1 | 1 | 2024-09-18 | 2024-10-24 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 710.32 Cr | 321.19 Cr | 389.13 Cr | 0.5478 | 0.00 Cr | 7.62 Cr | 337.22 Cr | 163.75 Cr | 9.44 | 248.35 Cr | 0.2305 |
| 2023-03-31 | 718.48 Cr | 448.16 Cr | 270.32 Cr | 0.3762 | 0.00 Cr | 5.44 Cr | 196.36 Cr | 160.03 Cr | 9.23 | 243.04 Cr | 0.2227 |
| 2022-03-31 | 676.78 Cr | 380.20 Cr | 296.58 Cr | 0.4382 | 0.00 Cr | 4.15 Cr | 222.43 Cr | 181.59 Cr | 10.47 | 268.68 Cr | 0.2683 |
| 2021-03-31 | 494.21 Cr | 246.73 Cr | 247.48 Cr | 0.5008 | 0.00 Cr | 6.39 Cr | 185.12 Cr | 138.42 Cr | 1,428.69 | 215.46 Cr | 0.2801 |
| 2020-03-31 | 538.20 Cr | 210.41 Cr | 327.78 Cr | 0.6090 | 0.00 Cr | 0.00 Cr | 200.68 Cr | 144.85 Cr | 8.35 | 218.63 Cr | 0.2691 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 40.95 Cr | 1,058.85 Cr | 213.62 Cr | 845.2230 Cr | 1.61 Cr | -39.34 Cr | 129.84 Cr | 318.80 Cr | 0.00 Cr | 0.00 Cr | 15.00 Cr | 205.9640 Cr |
| 2023-03-31 | 65.44 Cr | 862.07 Cr | 180.58 Cr | 681.4860 Cr | 4.94 Cr | -60.50 Cr | 129.14 Cr | 193.41 Cr | 0.02 Cr | 0.00 Cr | 0.00 Cr | 173.8790 Cr |
| 2022-03-31 | 75.37 Cr | 713.38 Cr | 191.83 Cr | 521.5420 Cr | 18.82 Cr | -56.56 Cr | 105.70 Cr | 161.92 Cr | 0.04 Cr | 0.00 Cr | 0.00 Cr | 174.5040 Cr |
| 2021-03-31 | 61.13 Cr | 536.28 Cr | 196.46 Cr | 339.8180 Cr | 53.12 Cr | -8.01 Cr | 118.62 Cr | 144.91 Cr | 7.41 Cr | 0.01 Cr | 0.00 Cr | 163.1050 Cr |
| 2020-03-31 | 10.07 Cr | 375.39 Cr | 172.65 Cr | 201.4160 Cr | 77.57 Cr | 67.49 Cr | 69.01 Cr | 109.19 Cr | 0.00 Cr | 0.00 Cr | 8.36 Cr | 133.2380 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 241.2570 Cr | -263.7550 Cr | -1.9860 Cr | 66.9590 Cr | -24.4840 Cr | 40.9540 Cr | -174.2980 Cr | 163.7510 Cr | -1.8250 Cr | -0.0020 Cr | -4.1770 Cr |
| 2023-03-31 | 141.5500 Cr | -147.2520 Cr | -4.2330 Cr | 82.2790 Cr | -9.9350 Cr | 65.4380 Cr | -59.2710 Cr | 160.0270 Cr | 0.0000 Cr | -0.0020 Cr | -20.6270 Cr |
| 2022-03-31 | 143.6730 Cr | -76.4640 Cr | -52.9630 Cr | 120.7510 Cr | 14.2460 Cr | 75.3730 Cr | -22.9220 Cr | 181.5910 Cr | -29.2430 Cr | -0.0020 Cr | 12.6850 Cr |
| 2021-03-31 | 129.9170 Cr | -56.6480 Cr | -22.1900 Cr | 80.7670 Cr | 51.0550 Cr | 61.1270 Cr | -49.1500 Cr | 141.6160 Cr | -22.2430 Cr | -0.0020 Cr | -48.6990 Cr |
| 2020-03-31 | 122.7290 Cr | -45.2360 Cr | -72.4970 Cr | 106.7170 Cr | 4.9960 Cr | 10.0720 Cr | -16.0120 Cr | 144.8470 Cr | -22.7400 Cr | 0.0000 Cr | 2.2040 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 318.38 Cr | 144.42 Cr | 173.96 Cr | 0.5464 | 119.27 Cr | 98.98 Cr | 5.71 | 137.26 Cr | 0.3109 |
| 2024-09-30 | 208.26 Cr | 109.53 Cr | 98.73 Cr | 0.4741 | 64.87 Cr | 58.35 Cr | 3.36 | 81.56 Cr | 0.2802 |
| 2024-06-30 | 162.90 Cr | 92.08 Cr | 70.82 Cr | 0.4348 | 40.78 Cr | 37.78 Cr | 2.18 | 52.98 Cr | 0.2319 |
| 2024-03-31 | 183.95 Cr | 107.82 Cr | 76.12 Cr | 0.4138 | 45.35 Cr | 39.65 Cr | 2.29 | 61.90 Cr | 0.2155 |
| 2023-12-31 | 166.76 Cr | 91.73 Cr | 75.03 Cr | 0.4499 | 46.73 Cr | 32.11 Cr | 1.85 | 51.59 Cr | 0.1925 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 29.83 Cr | 344.48 Cr | 374.31 Cr | 211.56 Cr | 178.03 Cr | 795.66 Cr | 352.69 Cr | 1,181.03 Cr | 257.03 Cr |
| 2024-06-30 | -320.19 Cr | 640.39 Cr | 320.19 Cr | 0.00 Cr | 0.00 Cr | 320.19 Cr | 0.00 Cr | 0.00 Cr | -845.22 Cr |
| 2024-03-31 | 84.71 Cr | 235.49 Cr | 320.19 Cr | 176.93 Cr | 129.84 Cr | 705.64 Cr | 318.80 Cr | 1,058.85 Cr | 213.62 Cr |
| 2023-12-31 | -282.96 Cr | 565.92 Cr | 282.96 Cr | 0.00 Cr | 0.00 Cr | 282.96 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 71.80 Cr | 211.16 Cr | 282.96 Cr | 205.71 Cr | 147.70 Cr | 696.53 Cr | 248.25 Cr | 963.52 Cr | 189.90 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 37.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 39.65 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 32.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 55.42 Cr | 55.42 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 47.87 Cr | 46.03 Cr | -56.80 Cr | -0.44 Cr | 5.17 Cr | 71.80 Cr | 66.63 Cr | -51.49 Cr | -5.46 Cr |
| 2023-06-30 | 44.12 Cr | 42.32 Cr | -40.13 Cr | -1.00 Cr | 1.19 Cr | 66.63 Cr | 65.44 Cr | -30.13 Cr | 12.19 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Biotechnology
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Biocon Limited | BIOCON | ₹331.90 | ₹398,479,140,000.00 | ₹1,860,996.00 |
| Piramal Pharma Limited | PPLPHARMA | ₹220.76 | ₹292,672,172,632.00 | ₹3,206,567.00 |
| Syngene International Limited | SYNGENE | ₹724.60 | ₹290,777,127,354.00 | ₹309,960.00 |
| Concord Biotech Limited | CONCORDBIO | ₹1,712.30 | ₹179,134,319,260.00 | ₹167,947.00 |
| Blue Jet Healthcare Limited | BLUEJET | ₹742.40 | ₹128,780,727,808.00 | ₹402,801.00 |
| Jubilant Ingrevia Limited | JUBLINGREA | ₹674.95 | ₹107,506,805,443.00 | ₹165,388.00 |
| Supriya Lifescience Limited | SUPRIYA | ₹743.80 | ₹59,863,106,640.00 | ₹485,094.00 |
| Dishman Carbogen Amcis Limited | DCAL | ₹210.73 | ₹33,038,902,663.00 | ₹169,506.00 |
| Panacea Biotec Limited | PANACEABIO | ₹504.80 | ₹30,919,375,571.00 | ₹556,110.00 |
| Zota Health Care Limited | ZOTA | ₹884.35 | ₹24,657,917,174.00 | ₹61,116.00 |
Key Executives
Gender: male
Year Born: 1963
Gender: female
Year Born:
Gender: female
Year Born: 1969
Gender: male
Year Born:
Gender: male
Year Born: 1965
Gender: male
Year Born: 1993
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
FAQs about Blue Jet Healthcare Limited
The CEO is Mr. Akshay Bansarilal Arora.
The current price is ₹742.40.
The range is ₹347.6-968.3.
The market capitalization is ₹12,878.07 crores.
The dividend yield is 0.13%.
The P/E ratio is 54.82.
The company operates in the Healthcare sector.
Overview of Blue Jet Healthcare Limited (ISIN: INE0KBH01020) is a leading Biotechnology in India. With a market capitalization of ₹12,878.07 crores and an average daily volume of 567,637 shares, it operates in the Biotechnology. The company last declared a dividend of ₹1.